Lataa...
Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone
The nonsteroidal mineralocorticoid receptor (MR) blocker esaxerenone has demonstrated good antihypertensive activity in a variety of patients, including those with uncomplicated grade I–III hypertension, hypertension with moderate renal dysfunction, hypertension with type 2 diabetes mellitus with al...
Tallennettuna:
| Julkaisussa: | Hypertens Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Singapore
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8019656/ https://ncbi.nlm.nih.gov/pubmed/33214722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41440-020-00569-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|